These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16708997)

  • 1. Chemogenomics approaches to G-protein coupled receptor lead finding.
    Klabunde T; Jäger R
    Ernst Schering Res Found Workshop; 2006; (58):31-46. PubMed ID: 16708997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemogenomics strategies for G-protein coupled receptor hit finding.
    Guba W
    Ernst Schering Res Found Workshop; 2006; (58):21-9. PubMed ID: 16708996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug design strategies for targeting G-protein-coupled receptors.
    Klabunde T; Hessler G
    Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug design of GPCR ligands using physicogenetics and chemogenomics--principles and case studies.
    Frimurer TM; Högberg T
    Curr Top Med Chem; 2011; 11(15):1882-901. PubMed ID: 21470174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.
    Kooistra AJ; Kuhne S; de Esch IJ; Leurs R; de Graaf C
    Br J Pharmacol; 2013 Sep; 170(1):101-26. PubMed ID: 23713847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-protein-coupled receptor affinity prediction based on the use of a profiling dataset: QSAR design, synthesis, and experimental validation.
    Rolland C; Gozalbes R; Nicolaï E; Paugam MF; Coussy L; Barbosa F; Horvath D; Revah F
    J Med Chem; 2005 Oct; 48(21):6563-74. PubMed ID: 16220973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Structural Framework for GPCR Chemogenomics: What's In a Residue Number?
    Vass M; Kooistra AJ; Verhoeven S; Gloriam D; de Esch IJP; de Graaf C
    Methods Mol Biol; 2018; 1705():73-113. PubMed ID: 29188559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemogenomics in drug discovery.
    Kubinyi H
    Ernst Schering Res Found Workshop; 2006; (58):1-19. PubMed ID: 16708995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for designing GPCR-focused libraries and screening sets.
    Jimonet P; Jäger R
    Curr Opin Drug Discov Devel; 2004 May; 7(3):325-33. PubMed ID: 15216936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T; Giegerich C; Evers A
    J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G protein-coupled receptor transmembrane binding pockets and their applications in GPCR research and drug discovery: a survey.
    Kratochwil NA; Gatti-McArthur S; Hoener MC; Lindemann L; Christ AD; Green LG; Guba W; Martin RE; Malherbe P; Porter RH; Slack JP; Winnig M; Dehmlow H; Grether U; Hertel C; Narquizian R; Panousis CG; Kolczewski S; Steward L
    Curr Top Med Chem; 2011; 11(15):1902-24. PubMed ID: 21470172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual Screening of Human Class-A GPCRs Using Ligand Profiles Built on Multiple Ligand-Receptor Interactions.
    Chan WKB; Zhang Y
    J Mol Biol; 2020 Aug; 432(17):4872-4890. PubMed ID: 32652079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
    Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing common substructures of ligands for GPCR protein subfamilies.
    Erguner B; Hattori M; Goto S; Kanehisa M
    Genome Inform; 2010; 24():31-41. PubMed ID: 22081587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Virtual Screening for Ligands of G Protein-Coupled Receptors: What Can Molecular Docking Do for You?
    Ballante F; Kooistra AJ; Kampen S; de Graaf C; Carlsson J
    Pharmacol Rev; 2021 Oct; 73(4):527-565. PubMed ID: 34907092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-protein coupled receptors virtual screening using genetic algorithm focused chemical space.
    Sage C; Wang R; Jones G
    J Chem Inf Model; 2011 Aug; 51(8):1754-61. PubMed ID: 21761904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.